本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Neumora Therapeutics, Inc.

0.7798
+0.01281.67%
盘前0.77990.0001+0.01%08:37 EDT
成交量:80.47万
成交额:61.38万
市值:1.26亿
市盈率:-0.51
高:0.7798
开:0.7630
低:0.7315
收:0.7670
数据加载中...
2025/04/11

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/03

重要事件披露

Form 8-K - Current report
2025/02/21

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/02

重要事件披露

Form 8-K - Current report
2024/11/22

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/13

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report